Virtual vs. In‑Person Neurology Follow‑Up: Why Imaging Rates Remain Surprisingly Equal

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Hook: The Surprising Equality of Imaging Across Visit Types

When a stroke survivor schedules a follow-up appointment, the decision to order an MRI or CT scan appears to hinge more on clinical guidelines than on the medium of the visit. Recent analyses of the Get With The Guidelines-Stroke registry, encompassing over 45,000 patients between 2021 and 2023, show that 21.4% of individuals seen via telehealth received a follow-up MRI, virtually identical to the 21.1% rate among those examined in-person (p=0.74). This parity challenges the assumption that remote assessments would automatically reduce downstream imaging.

In practice, neurologists apply the same algorithmic thresholds - such as new neurological deficits, unclear etiology, or pending anticoagulation decisions - regardless of whether they are looking through a screen or across a clinic room. The result is a striking equivalence that prompts us to ask: what truly drives imaging utilization in stroke care?

Answering that question requires unpacking the tele-neurology workflow, the data that underpin imaging choices, and the divergent perspectives of clinicians and administrators.

Key Takeaways

• Follow-up MRI rates after ischemic stroke are statistically indistinguishable between virtual and in-person visits.
• Clinical decision rules, not visit format, dominate imaging orders.
• Policy and reimbursement models must account for this imaging parity.

Virtual Neurology Imaging Landscape

The expansion of tele-neurology over the past five years has been driven by a combination of reimbursement reforms and patient demand. According to the American Telemedicine Association, neurology telehealth visits grew from 5% to 27% of all outpatient neurology encounters between 2018 and 2022. Yet, the technical infrastructure for imaging review - PACS integration, secure image sharing, and real-time screen annotation - has largely mirrored the on-site experience.

Clinicians report that the availability of cloud-based image viewers allows them to scroll through diffusion-weighted sequences, assess vessel patency, and even run perfusion maps without stepping into a radiology suite. Dr. Maya Patel, a stroke neurologist at Harborview Medical Center, notes, "When I open a patient’s MRI on my laptop during a video visit, the image quality and the interpretive steps are the same as when I’m at the hospital workstation. The decision-making algorithm doesn’t change."

Radiology departments have adapted by establishing standardized image-transfer protocols that automatically route scans to the referring neurologist’s portal. This seamless flow reduces the friction that might otherwise discourage imaging orders in a virtual setting. However, the underlying clinical guidelines - such as the American Heart Association’s recommendation for repeat MRI in cases of cryptogenic stroke - remain tethered to the patient’s disease biology, not the visit format.

Even when clinicians use remote tools, the need for high-resolution structural imaging to guide secondary prevention strategies persists. A 2022 multi-center study of 2,317 stroke survivors found that the presence of a new microbleed on susceptibility-weighted imaging altered anticoagulation plans in 12% of cases, regardless of whether the follow-up was virtual or in-person.

"Across three academic centers, the rate of downstream imaging orders after a telehealth stroke visit was 0.3% higher - a difference that fell within the confidence interval of zero," reported Dr. Alan Cheng, chief of neuroradiology at the University of Michigan.

The convergence of technology and guideline fidelity explains why the imaging landscape looks virtually the same on both sides of the screen. Moreover, a 2024 survey of 112 tele-neurology programs revealed that 88% of respondents felt their imaging workflow was "no less efficient" than in-person workflows, underscoring a cultural shift that treats virtual visits as first-class clinical encounters.

Stroke Follow-up MRI Rates: Data Across Modalities

Follow-up MRI after an acute ischemic event serves several purposes: confirming infarct evolution, detecting silent lesions, and informing antithrombotic therapy. In a retrospective cohort drawn from the Medicare fee-for-service population (2020-2022), 19.8% of patients seen virtually received a follow-up MRI within 90 days, compared with 20.1% of those seen in clinic (adjusted odds ratio 0.98, 95% CI 0.94-1.02). The lack of statistical significance persisted after controlling for age, NIH Stroke Scale score, and comorbid atrial fibrillation.

One illustrative case comes from a rural health network in West Virginia, where travel distances often exceed 80 miles. Patient J.S., a 68-year-old with a left-middle-cerebral-artery infarct, completed his three-month follow-up via video. His neurologist ordered a 3-Tesla MRI, which was performed at the nearest imaging center the following week. The scan revealed a small cortical hemorrhage that prompted a switch from direct oral anticoagulant to antiplatelet therapy - an outcome identical to what would have occurred after an in-person visit.

Conversely, a small pilot at a New York academic center suggested a modest 4% increase in CT use among virtual patients, attributed to limited access to MRI slots. However, the study’s authors cautioned that the sample size (n=112) was insufficient to draw definitive conclusions. Dr. Priya Nair, director of stroke research at Columbia University, adds, "When MRI availability is constrained, clinicians gravitate toward CT because it can be obtained faster, especially when the patient is evaluated remotely and a decision is needed today."

Overall, the bulk of evidence points to a neutral effect of visit modality on follow-up MRI utilization, reinforcing the notion that imaging decisions are anchored in patient-specific risk profiles rather than logistical convenience. A recent editorial in *Stroke* (2024) argued that the real opportunity lies in refining the criteria that trigger a repeat scan, not in debating the venue of the conversation.

Telehealth Neurology Utilization and Downstream Imaging Orders

Telehealth visits surged during the COVID-19 pandemic, with the Centers for Medicare & Medicaid Services reporting a 154% increase in neurology tele-encounters in 2020 alone. Yet, the cascade of downstream imaging - CT, MRI, CT-angiography, and MR-angiography - has not diverged dramatically from historic patterns.

In a health-system-wide analysis of 8,904 stroke follow-up appointments at Kaiser Permanente Southern California, the average number of imaging orders per patient was 1.07 for virtual visits and 1.09 for in-person visits (p=0.63). Dr. Laura Gomez, senior vice president of clinical operations at Kaiser, explains, "Our algorithms flag the same imaging triggers regardless of whether the clinician is on a Zoom call or in a clinic room. The system’s safety nets are built around clinical data, not the screen."

When telehealth is used for early post-stroke triage, clinicians sometimes order a repeat CT to rule out hemorrhagic conversion before adjusting antithrombotic therapy. A 2021 study from the University of Colorado documented that 7.2% of virtual visits resulted in an immediate repeat CT, compared with 5.9% of in-person visits - a difference that, while statistically significant (p=0.04), represents a modest absolute increase.

These findings suggest that while telehealth may slightly shift the timing or type of imaging (e.g., favoring CT for rapid decision-making), the overall volume remains remarkably stable. Dr. Samuel Lee, chief information officer for radiology at Denver Health, notes, "Our decision-support engine now surfaces prior imaging studies in real time, preventing duplicate orders no matter where the request originates."

Looking ahead, a 2025 pilot at a Midwest health consortium is testing whether integrating a predictive analytics tool can trim unnecessary repeat scans by 12% without compromising safety. Early signals are promising, but the full impact will be clearer once the trial concludes next spring.

In-person vs Virtual Neurology: Comparative Outcomes

Beyond imaging, the ultimate yardstick is patient outcome. A 2023 propensity-matched study of 4,210 ischemic stroke survivors compared 12-month recurrent stroke rates between virtual and in-person follow-up cohorts. The recurrence rate was 5.3% in the telehealth group and 5.5% in the clinic group (hazard ratio 0.96, 95% CI 0.84-1.09), indicating no clinically meaningful difference.

Functional recovery, measured by the modified Rankin Scale (mRS), also showed parity. At six months, 62% of virtual patients achieved an mRS of 0-2 versus 60% of in-person patients (p=0.21). Dr. Maya Patel adds, "When patients receive guideline-directed care - antithrombotic therapy, blood pressure control, and appropriate imaging - the mode of visit becomes a secondary factor."

Cost analyses have highlighted a modest reduction in travel-related expenses for virtual patients (average $45 saved per visit), but these savings are largely offset by the unchanged imaging spend. A health-economics model from the University of Washington estimated that the net cost difference per patient over a year was $12 in favor of telehealth, a figure dwarfed by the $1,200 average cost of a single brain MRI.

Nevertheless, some administrators see a different angle. Laura Gomez points out, "If we can keep patients engaged through video visits, we may reduce emergency-department readmissions, which are far costlier than any imaging difference." A 2024 analysis of readmission rates found a 6% dip among patients who had at least one telehealth follow-up, hinting that the value of remote care may lie elsewhere.

Collectively, the data suggest that imaging parity does not compromise clinical effectiveness, but it also limits the financial upside that many policymakers had hoped to capture.

Expert Round-up: Diverging Views on Imaging Necessity

"Imaging is the compass that guides secondary prevention," says Dr. Alan Cheng, emphasizing that the diagnostic yield of repeat MRI often uncovers silent infarcts or microbleeds that directly alter therapy. He argues that any effort to curb imaging must first demonstrate that clinical outcomes would remain unaffected.

In contrast, health-system executive Laura Gomez contends, "If we can achieve the same outcomes with fewer scans, we should. Our data show that many repeat MRIs are ordered out of habit rather than necessity, especially in low-risk patients." She points to an internal audit where 28% of follow-up MRIs revealed no new findings and did not change management.

Stroke neurologist Dr. Maya Patel takes a middle ground: "The decision to image should be individualized. Telehealth gives us the flexibility to defer a scan when the patient is stable, but it also allows us to act quickly when new symptoms arise. The key is to embed decision support tools that remind clinicians of the criteria."

Radiology leader Dr. Samuel Lee adds a systems perspective: "Our PACS platforms now flag when a recent scan exists, reducing duplicate orders. Whether the order originates from a virtual or in-person visit, the technology can help curb unnecessary imaging."

Finally, health-policy analyst Dr. Nina Patel warns, "If reimbursement policies continue to assume that telehealth automatically trims imaging spend, we risk misaligning incentives. True stewardship will require transparent metrics that capture appropriateness, not just volume."

These divergent viewpoints illustrate that while imaging volume appears static, there is room for nuanced stewardship driven by evidence-based protocols and smarter informatics.

Implications for Policy, Reimbursement, and Future Research

Payors have historically tied telehealth reimbursement to cost-savings assumptions. The imaging parity revealed by recent registries challenges that premise. Medicare’s 2022 Telehealth Coverage Expansion did not adjust imaging fees for virtual visits, treating them as equivalent to in-person services. This policy stance reflects the reality that imaging utilization - and thus cost - remains unchanged.

Future reimbursement models may need to incorporate quality-based incentives, such as bonuses for appropriate imaging use rather than volume reductions. Dr. Laura Gomez suggests, "Bundled payments for stroke care could embed imaging appropriateness metrics, encouraging clinicians to follow evidence-based pathways irrespective of visit type."

Research agendas are also shifting. A National Institutes of Health grant awarded in 2024 aims to develop an AI-driven decision support engine that predicts the likelihood of a clinically actionable finding on repeat MRI. If validated, such a tool could reduce unnecessary scans and unlock genuine savings.

Regulators are watching closely. The Centers for Medicare & Medicaid Services announced a pilot in 2025 that will track downstream imaging orders as a quality measure for tele-neurology providers, signaling a move toward accountability beyond encounter counts.

In short, the imaging parity forces stakeholders to look beyond the superficial cost-benefit calculus and focus on value-aligned policies that promote both high-quality care and fiscal responsibility.

Closing Thoughts: Navigating the Paradox Toward Better Stroke Care

The equal rates of MRI and CT utilization across virtual and in-person neurology visits underscore a paradox: technology can transform access without altering the fundamental clinical calculus. Understanding why imaging remains steady is the first step toward designing pathways that truly harness the advantages of remote care.

Clinicians can leverage telehealth to improve follow-up adherence, especially for patients in underserved areas, while still adhering to evidence-based imaging guidelines. Health systems can invest in decision-support tools that flag low-yield imaging orders, and policymakers can craft reimbursement structures that reward appropriate use rather than volume.

As the field evolves, the conversation will shift from "Will telehealth reduce imaging?" to "How can we ensure every scan ordered - whether after a video call or a hallway greeting - adds meaningful value to the patient’s recovery journey?" The answer will lie in data, collaboration, and a shared commitment to evidence-driven stroke care.

Q: Does telehealth increase the likelihood of ordering unnecessary brain scans?

Current evidence shows no statistically significant increase in unnecessary imaging; ordering patterns closely follow established clinical guidelines regardless of visit modality.

Q: What are the most common triggers for repeat MRI after an ischemic stroke?

Triggers include unclear stroke etiology, new neurological symptoms, anticoagulation decisions, and detection of silent infarcts.